Biosimilar Bevacizumab Market Poised for Robust Growth as...

добавлена новая статья Health

2026-04-04 08:04:36 -

The global Biosimilar Bevacizumab Market is on a robust growth trajectory, driven by the increasing demand for affordable cancer treatments, the expiration of patents on the reference biologic Avastin, and supportive regulatory frameworks. According to a comprehensive report by Market Research Future, the market was valued at USD 1.814 billion in 2024. It is projected to grow from USD...

0 Комментарии 0 Поделились 10 Просмотры 0 предпросмотр